Decision of the Independent Allocation of Vaccines Group on the allocation of COVAX Facility secured vaccines: 27 January 2022

Overview

COVAX Allocation Round 14 (R14) is the first allocation round with greater supply than demand, with over 400M doses communicated to the Joint Allocation Taskforce available for allocation. This novel situation required several policy decisions to manage the allocation, including prioritization of supply sources (APA vs. donations) and products. Considerations on Participants’ demand also needed to reflect on changes in the delivery scope for the R14 allocations, as the round launch communications were originally sent to Participants in December 2021. At that time, R14 was expected to allocate the residual, limited quantities of supply available for shipment in Q1-2022.